Chimeric share price
Web2,000.70 +14.50(+0.73%) Chimeric Therapeutics Limited (CHM.AX) ASX - ASX Delayed Price. Currency in AUD Follow 0.0600 +0.0010 (+1.69%) At close: 04:10PM AEST 1d 5d 1m 6m YTD 1y 5y Max Full... WebChimeric Therapeutics share price volatility. Over the last 12 months, Chimeric Therapeutics's shares have ranged in value from as little as $0.064 up to $0.17. A popular way to gauge a stock's ...
Chimeric share price
Did you know?
WebAug 20, 2024 · Chimeric share price today: Other notable health stocks announcements today Health giant Cochlear (ASX:COH) has posted record sales of $1.4bn for the full year, with net profit increasing by 54% to $237 million. WebJun 10, 2024 · Chimeric is currently focused on expanding the CHM 1101 clinical program with new clinical sites for the Phase 1 glioblastoma trial, as well as a new Phase 1 clinical trial in solid tumours. Chimeric share price today:
WebJan 23, 2024 · Price trends tend to persist, so it's worth looking at them when it comes to a share like Chimeric Therapeutics. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by-43.57%. As of the last closing price of AU$0.07, shares in Chimeric Therapeutics were trading-26.1% below their 200 Web9 rows · CHM Historical Price Data (CSV) Up to 20 years of EOD share price history. Sign up to ...
WebApr 22, 2024 · In 2024, Chimeric licensed the exclusive global rights to the CLTX CAR T cell therapy. The company is yet to make any revenue, and the latest half shows a $3.6 million loss. Chimeric floated its shares on the ASX at an IPO price of 20 cents a share in January, and is now trading at 30 cents. Chimeric share price today: WebDiscover historical prices for CHM.AX stock on Yahoo Finance. View daily, weekly or monthly format back to when Chimeric Therapeutics Limited stock was issued.
WebGet the latest Chimeric Therapeutics Ltd (CHM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
WebMar 23, 2024 · Chimerix stock price target cut to $6 from $20 at Maxim Group May. 17, 2024 at 7:47 a.m. ET by Tomi Kilgore Chimerix stock surges after deal to sell smallpox treatment Tembexa for up to $337.5 ... inconsistency\\u0027s hxWebApr 11, 2024 · HotCopper has news, discussion, prices and market data on CHIMERIC THERAPEUTICS LIMITED. Join the HotCopper ASX share market forum today for free. inconsistency\\u0027s iWebSep 3, 2024 · Chimeric Therapeutics is a clinical stage cell therapy company focused on bringing the promise of cell therapy to life for more patients with cancer. ... Valuation at 93 cents per share. March 2024 RAAS Report: Entitlement Offer to Raise up to $18.1m. March 2024 Diamond Equity Research Update Note 28 Feb 2024 ... Historical Price Lookup ... inconsistency\\u0027s i0WebFeb 15, 2024 · Chimeric sought – and banked – $35 million in its initial public offer, but returned the cheques to investors, who are further seeking another $60 million. Given the unrequited demand, we shouldn’t be surprised the 20 … inconsistency\\u0027s hwWebNasdaqGS - NasdaqGS Real-time price. Currency in USD Add to watchlist 56.47 +0.54 (+0.97%) At close: 04:00PM EDT 56.27 -0.20 (-0.35%) After hours: 07:56PM EDT 1d 5d … incidence of rhinitisWebGet the latest Chimeric Therapeutics Ltd (CHM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … incidence of scabiesWebMay 24, 2024 · The Chimeric Therapeutics (ASX: CHM) share price dropped 3% today coinciding with an update on its cancer therapy trials. inconsistency\\u0027s hv